Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Oxaliplatin Taj Pharmaceuticals Ltd

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  
Oxaliplatin Manufacturers in India Suppliers Oxaliplatin Dossage Exporters Distributors Oxaliplatin api active pharmaceuticals ingredients Oxaliplatin manufacturers Side Effects bulk drugs raw material Dossage Oxaliplatin companies Side Effects Dossage Importers Oxaliplatin Dossage Oxaliplatin Exporters Oxaliplatin exporters Dossage FDA Dossage Oxaliplatin Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd. active pharmaceutical ingredients suppliers pharmaceutical Oxaliplatin manufacturing pharmaceutical drugs pharmaceutical intermediates Oxaliplatin pharmaceutical chemicals pharmaceutical raw materials Oxaliplatin active pharmaceutical ingredients Oxaliplatin committee active pharmaceutical ingredients manufacturer Oxaliplatin Active Pharmaceutical Ingredients manufacturer Oxaliplatin exporter drug ingredients pharmaceuticals Pharmaceuticals API Manufacturer Oxaliplatin, Oxaliplatin manufacturer India, Oxaliplatin product, Oxaliplatin products, Api preparation, Certificate of Analysis API manufacturer product, Oxaliplatin anti ulcer product, Certificate of Origin COA Oxaliplatin COS Oxaliplatin, pharmaceutical generic, pharmaceutical drug, medical, Oxaliplatin pharma healthcare, pharma patents, contract MSDS manufacturing Trader Oxaliplatin pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Oxaliplatin expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Oxaliplatin DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Oxaliplatin ingredients, api, HIV Oxaliplatin, tablets, capsules, syrup & protein Oxaliplatin powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Oxaliplatin gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Oxaliplatin WHO, UKMHRA Approval
   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

api image Pharma1














 

 





 

 

 

 

HOME >> API >> API List 3 >> Oxaliplatin >> Dosage

Oxaliplatin CAS Registry Number 61825-94-3


DOSAGE
Oxaliplatin CAS Registry Number 61825-94-3


Oxaliplatin may be given:

* by injection into a vein (intravenously), through a fine tube (cannula) inserted into the vein
* through a central line, which is inserted under the skin into a vein near the collarbone, or into a PICC line, which is inserted into a vein in the crook of the arm.

Chemotherapy is usually given as a course of several sessions (or cycles) of treatment over a few months. The length of your treatment and the number of cycles you have will depend on the type of cancer for which you are being treated. Your nurse or doctor will discuss your treatment plan with you.

Oxaliplatin  in combination with 5-FU/LV every 2 weeks. For advanced disease, treatment is recommended until disease progression or unacceptable toxicity. For adjuvant use, treatment is recommended for a total of 6 months (12 cycles):

Day 1: Oxaliplatin  85 mg/m2 IV infusion in 250-500 mL 5% Dextrose injection, USP (D5W) and Oxaliplatin  200 mg/m2 IV infusion in D5W both given over 120 minutes at the same time in separate bags using a Y-line, followed by 5-FU 400 mg/m2 IV bolus given over 2-4 minutes, followed by 5-FU 600 mg/m2 IV infusion in 500 mL D5W (recommended) as a 22-hour continuous infusion.

Day 2: Oxaliplatin  200 mg/m2 IV infusion over 120 minutes, followed by 5-FU 400 mg/m2 IV bolus given over 2-4 minutes, followed by 5-FU 600 mg/m2 IV infusion in 500 mL D5W (recommended) as a 22-hour continuous infusion.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE >>
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Oxaliplatin

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.